Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 3)

Aphasia (Phase 3)

Breast Neoplasms (Phase 2)

Cardiac Output, Low (Phase 3)

Cardiomyopathies (Phase 3)

Cardiomyopathy, Dilated (Phase 3)

Communicable Diseases (Phase 3)

Coronavirus Infections (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Diabetic Foot (Phase 3)

Eczema (Phase 2)

Erectile Dysfunction (Phase 3)

Food Hypersensitivity (Phase 2)

Foot Ulcer (Phase 3)

Fragile X Syndrome (Phase 2)

Glioblastoma (Phase 2)

Head and Neck Neoplasms (Phase 2)

Heart Failure (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hypersensitivity (Phase 2)

Hypogonadism (Phase 3)

Infections (Phase 3)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Lupus Nephritis (Phase 3)

Mucositis (Phase 2)

Nephritis (Phase 3)

Obesity (Phase 3)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 3)

Sarcoma (Phase 2)

Severe Acute Respiratory Syndrome (Phase 3)

Stomatitis (Phase 2)

Stroke (Phase 3)

Syndrome (Phase 2)

Ulcer (Phase 3)